Undetectable Serum Thyroglobulin in a Patient With Metastatic Follicular Thyroid Cancer
Authors:
- Ilse J. R. MertensIMIlse J. R. Mertens
- John M. H. DE KlerkJKJohn M. H. DE Klerk
- Pierre M. J. ZelissenPZPierre M. J. Zelissen
- Jos H. H. ThijssenJTJos H. H. Thijssen
- Daisy M. D. S. Sie-GoDSDaisy M. D. S. Sie-Go
- Shiuw H. HanSHShiuw H. Han
- Peter P. VAN RijkPRPeter P. VAN Rijk
- 1 May 1999
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 24 (5) , 346-349
Abstract
The case of a 54-year-old woman with metastatic follicular thyroid cancer and undetectable serum thyroglobulin is presented. Many years after the patient had a subtotal thyroidectomy for a large goiter that had no clear evidence of malignancy, metastatic bone disease developed. When the bone metastases were detected and during the follow-up period, serum thyroglobulin values remained undetectable, but radioiodine uptake in the metastases was abundant. This case indicates that the combination of I-131 scintigraphy and serum thyroglobulin values is superior to the measurement of serum thyroglobulin alone in detecting well-differentiated, metastatic thyroid cancer.Keywords
This publication has 11 references indexed in Scilit:
- Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scanThe Journal of Clinical Endocrinology & Metabolism, 1995
- Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancerThe Journal of Clinical Endocrinology & Metabolism, 1994
- Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinomaThe Journal of Clinical Endocrinology & Metabolism, 1994
- Thyroglobulin measurement vs iodine 131 total-body scan for follow-up of well-differentiated thyroid cancerArchives of internal medicine (1960), 1990
- Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1990
- Clinical evaluation of tumor characteristics predisposing serum thyroglobulin to be undetectable in patients with differentiated thyroid cancerCancer, 1988
- Long-Term Results of Treatment of 283 Patients with Lung and Bone Metastases from Differentiated Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 1986
- Thyroglobulin may be undetectable in the serum of patients with metastatic disease secondary to differentiated thyroid carcinoma. Follow-up of differentiated thyroid carcinomaCancer, 1984
- The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancerThe American Journal of Medicine, 1981
- Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas.Journal of Clinical Investigation, 1975